EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Stimuli-Responsive Peptides for Targeted Anticancer Drug Delivery: Current Advances and Future Outlook

Oindrila Palit iD, Ankita Das iD, Supriya Bharti iD, Eirinaios I Vrettos iD, Sankarprasad Bhuniya iD

Pharmaceutics · 13.06.2026 · 18 (6) · 732

DOI: 10.3390/pharmaceutics18060732 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 13.06.2026. Verfasst von Oindrila Palit und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Interdisciplinary Sciences, JIS Institute of Advanced Studies and Research, JIS University, 51, South Nayabaz, GIP Colony, Santragachi, Ni…. Die Arbeit nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Engineering Research Board, SERB, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Efficient delivery systems are essential for transporting chemotherapeutic agents to target sites, enhancing cellular uptake and reducing off-target side effects. Peptides, owing to their intrinsic biocompatibility and structural tunability, have emerged as promising carriers for delivering labile chemotherapeutics and improving pharmacokinetics and therapeutic outcomes. Along these lines, a wide variety of peptide-based delivery strategies have been developed to achieve desirable pharmaceutical properties for anticancer agents. Particularly, stimuli-responsive peptide-based nanocarriers have attracted high levels of attention due to their ability to exploit overexpressed or tumor-specific stimuli, enabling selective disassembly and controlled drug release within cancer cells. In this review, we highlight recent advances in the development of stimuli-responsive peptide nanocarriers and their applications in anticancer therapy, and discuss key challenges and future directions toward their clinical translation.

Schlagwörter

Stichwörter der Autor:innen

ROSapoptosisenzymeshypoxiain vivopeptidestimuli-responsivetumor

Autor:innen und Institutionen

  • Centre for Interdisciplinary Sciences, JIS Institute of Advanced Studies and Research, JIS University, 51, South Nayabaz, GIP Colony, Santragachi, Nibra, Howrah 711302, West Bengal, India.
  • Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.

ORCID-Profile: Oindrila Palit, Ankita Das, Supriya Bharti, Eirinaios I Vrettos, Sankarprasad Bhuniya

Förderung

  • Science and Engineering Research Board
  • SERB, India

Zitieren

APA

Palit, O., Das, A., Bharti, S., Vrettos, E. I., & Bhuniya, S. (2026). Stimuli-Responsive Peptides for Targeted Anticancer Drug Delivery: Current Advances and Future Outlook. Pharmaceutics, 18(6), 732. https://doi.org/10.3390/pharmaceutics18060732

Vancouver

Palit O, Das A, Bharti S, Vrettos EI, Bhuniya S. Stimuli-Responsive Peptides for Targeted Anticancer Drug Delivery: Current Advances and Future Outlook. Pharmaceutics. 2026;18(6):732. doi:10.3390/pharmaceutics18060732

BibTeX
@article{Palit2026,
  author = {Palit, Oindrila and Das, Ankita and Bharti, Supriya and Vrettos, Eirinaios I and Bhuniya, Sankarprasad},
  title = {Stimuli-Responsive Peptides for Targeted Anticancer Drug Delivery: Current Advances and Future Outlook},
  journal = {Pharmaceutics},
  year = {2026},
  volume = {18},
  number = {6},
  pages = {732},
  doi = {10.3390/pharmaceutics18060732}
}
Kostenlos starten →